“According to a new report published by Introspective Market Research, Vascular Closure Device Market by Product Type, Access Site, and End User, The Global Vascular Closure Device Market Size Was Valued at USD 1.46 Billion in 2023 and is Projected to Reach USD 2.32 Billion by 2032, Growing at a CAGR of 5.30% from 2024 to 2032.”
The vascular closure device market is witnessing steady growth driven by the increasing adoption of minimally invasive cardiovascular and interventional procedures. Vascular closure devices are used to achieve hemostasis at arterial puncture sites following catheter-based procedures, reducing complications, accelerating patient recovery, and improving procedural efficiency compared to traditional manual compression methods.
These devices offer significant clinical advantages, including shorter ambulation time, reduced bleeding risk, enhanced patient comfort, and lower hospital stay durations. They are widely used across diagnostic and therapeutic procedures such as angiography, angioplasty, transcatheter valve replacement, and electrophysiology interventions.
Rising prevalence of cardiovascular diseases, technological advancements in closure device design, and the growing preference for same-day discharge procedures are collectively fueling demand for vascular closure devices across hospitals, ambulatory surgical centers, and specialty clinics worldwide.
Market Segmentation
The Vascular Closure Device Market is segmented into Product Type, Access Site, and End User.
By Product Type, the market is categorized into Active Closure Devices, Passive Closure Devices, and External Hemostatic Devices.
By Access Site, the market is categorized into Femoral Access and Radial Access.
By End User, the market is categorized into Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.
Growth Driver
The primary growth driver of the vascular closure device market is the rising volume of minimally invasive cardiovascular and peripheral vascular procedures globally. Increasing incidences of coronary artery disease, peripheral artery disease, and structural heart disorders have led to higher utilization of catheter-based interventions. Vascular closure devices significantly reduce post-procedural complications and enable faster patient mobilization, making them a preferred choice over manual compression. Additionally, favorable reimbursement policies and growing clinician awareness regarding procedural efficiency and patient outcomes are accelerating market growth across developed and emerging healthcare systems.
Market Opportunity
An emerging opportunity in the vascular closure device market lies in the growing adoption of radial access procedures and advancements in bioabsorbable closure technologies. Manufacturers are focusing on developing next-generation devices that offer enhanced safety, reduced infection risk, and compatibility with a wider range of sheath sizes. Expanding healthcare infrastructure in emerging economies, coupled with increasing investments in interventional cardiology and radiology departments, is expected to create lucrative growth opportunities. Furthermore, the shift toward outpatient and same-day discharge procedures is opening new avenues for market expansion.
Detailed Segmentation
Vascular Closure Device Market, Segmentation
The Vascular Closure Device Market is segmented on the basis of Product Type, Access Site, and End User.
Product Type
The Product Type segment is further classified into Active Closure Devices, Passive Closure Devices, and External Hemostatic Devices. Among these, the Active Closure Devices sub-segment accounted for the highest market share in 2023. Active closure devices provide rapid hemostasis and improved procedural efficiency, making them widely adopted in high-volume catheterization laboratories. Their ability to reduce time to ambulation and minimize post-procedural complications has positioned them as the preferred option among healthcare providers, particularly in complex cardiovascular interventions.
Access Site
The Access Site segment is further classified into Femoral Access and Radial Access. Among these, the Femoral Access sub-segment accounted for the highest market share in 2023. Femoral access remains the dominant approach due to its widespread use in complex interventional procedures requiring larger sheath sizes. Vascular closure devices designed for femoral access offer effective closure, reduced bleeding risk, and faster recovery, thereby maintaining strong demand despite the rising adoption of radial access techniques.
Some of The Leading/Active Market Players Are-
• Abbott Laboratories (USA)
• Terumo Corporation (Japan)
• Cardinal Health, Inc. (USA)
• Medtronic plc (Ireland)
• Teleflex Incorporated (USA)
• B. Braun Melsungen AG (Germany)
• Merit Medical Systems, Inc. (USA)
• Cordis (USA)
• Haemonetics Corporation (USA)
• Nipro Corporation (Japan)
• Essential Medical, Inc. (USA)
• Vascular Solutions, Inc. (USA)
• Boston Scientific Corporation (USA)
• SCION Medical Technologies (USA)
• Morpheus Medical (USA)
and other active players.
Key Industry Developments
In March 2024, a leading medical device manufacturer announced the launch of a next-generation bioabsorbable vascular closure device designed to enhance safety and reduce infection risks.
The new device focuses on faster hemostasis and improved patient comfort, supporting the growing trend toward minimally invasive and outpatient cardiovascular procedures.
In October 2023, a prominent market player expanded its vascular closure device portfolio through a strategic acquisition aimed at strengthening its interventional cardiology offerings.
This development is expected to enhance product availability and accelerate innovation in closure technologies across global healthcare markets.
Key Findings of the Study
• Active closure devices dominated the product segment due to faster hemostasis
• Femoral access remained the leading access site segment
• North America held the largest market share
• Rising minimally invasive procedures drove market growth
• Technological advancements remain a key market trend
More Info:- https://introspectivemarketresearch.com/reports/vascular-closure-device-market/
About Us
At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Vascular Closure Device Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global Vascular Closure Device industry.
đ Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek